RL Pande, M Park, TS Perlstein… - … and Vascular Biology, 2011 - Am Heart Assoc Methods and Results— Thirty-seven subjects with PAD and claudication and 11 healthy controls underwent [ 18 F]fluorodeoxyglucose–positron emission tomography imaging of the legs during hyperinsulinemic-euglycemic clamp. Calf glucose uptake was quantified by graphical ... Cited by 1 - Related articles - All 2 versions
ZA Fayad, V Mani, M Woodward, D Kallend… - American Heart …, 2011 - Elsevier Patients with CHD or CHD-risk equivalents were randomized to receive 600 mg dalcetrapib or placebo daily for 24 months, in addition to conventional lipid-lowering medication and other medications for cardiovascular risk factors. The primary outcomes are the effect of dalcetrapib on 18F- ...
S Subramanian, M Lawler… - Journal of the …, 2011 - Am Coll Cardio Found ... and Ahmed Tawakol Sharath Subramanian, Meredith Lawler, Jayanthi Vijayakumar, Amr Abdelbaky, INFLAMED AND LIPID-RICH AORTIC PLAQUES AND MAGNETIC RESONANCE IMAGING FOR LOCALIZATION OF 18 F-FLUORODEOXYGLUCOSE POSITRON EMISSION ... All 2 versions
N Pipitone, A Versari, A Vaglio… - Clinical and experimental …, 2011 - ncbi.nlm.nih.gov Retroperitoneal fibrosis is a syndrome characterised by the presence of fibrosclerotic tissue in the retroperitoneum, often encasing the ureters. In most cases, retroperitoneal fibrosis is idiopathic, but may also be associated with large vessel vasculitis at distant sites, with the ...
S Nakamura, K Okochi… - Journal of Computer …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > Current ... Related articles - All 2 versions